• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ECLIPSE FILTER SYSTEM - FEMORAL; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ECLIPSE FILTER SYSTEM - FEMORAL; VENA CAVA FILTER Back to Search Results
Catalog Number EC500F
Device Problems Malposition of Device (2616); Detachment of Device or Device Component (2907); Patient Device Interaction Problem (4001)
Patient Problems Extravasation (1842); Hemorrhage/Bleeding (1888)
Event Date 04/11/2010
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process, and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.Medical records were not provided.Therefore, the investigation is inconclusive for filter tilt, perforation of the ivc and filter limb detachment as no objective evidence has been provided to confirm any alleged deficiency with the filter.Based on the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(expiry date: 01/2013).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism and in conjunction with or before bariatric procedure.At some time post filter deployment, it was alleged that filter tilted and embedded in the wall of the ivc; struts were detached and perforated outside the ivc and bleeding.The device was removed percutaneously.It was further reported that the detached strut retained in neck.The patient experienced retroperitoneal hemorrhage; however, the current status of the patient is unknown.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism, in conjunction with or before bariatric procedure.At some time post filter deployment, it was alleged that filter tilted and embedded in the wall of the ivc; struts were detached and retained in neck and perforated outside the ivc and bleeding.The device was removed percutaneously.The patient experienced retroperitoneal hemorrhage; however, the current status of the patient is unknown.
 
Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process, and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.After one month and six days of post filter deployment, computed tomography (ct) scanning was revealed that inflammation and blood along the right side of the inferior vena cava filter which was placed over l2, had migrated down to l4 with a couple of the legs outside the vena cava with some retroperitoneal bleeding.Subsequent impression from ct was revealed the tilt of the filter and two or three of the tines were outside of the inferior vena cava.One day later, on 12-apr-2010 an retrieval attempt was made with the right internal jugular vein with bard retrievable device, but it was not successful the retrieval was very difficult.An second attempt made with variety of sizes of gooseneck snares and an ensnare but still not able to retrieve the filter.The filter appeared to be embedded in the wall.The left common femoral vein was cannulated, the filter was retrieved entirely.Therefore, the investigation is confirmed for perforation of the ivc, filter migration, filter tilt and retrieval difficulties.However, the investigation is inconclusive for filter limb detachment.Per medical records, multiple attempts were made to engage the filter using snare but were unsuccessful due to filter tilt and embedment.This could have contributed to the retrieval difficulties.However, the definitive root cause is unknown.Labeling review: instructions for use: warnings: the safety and effectiveness of this device has not been established for morbidly obese patients.Open abdominal procedures such as bariatric surgery may affect the integrity and stability of the filter a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ECLIPSE FILTER SYSTEM - FEMORAL
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key9610225
MDR Text Key175923829
Report Number2020394-2020-00658
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
PMA/PMN Number
K093659
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Type of Report Initial,Followup
Report Date 05/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/21/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberEC500F
Device Lot NumberGFUA1299
Was Device Available for Evaluation? No
Date Manufacturer Received05/08/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
COUMADIN, GLUCOPHAGE, PAXIL, FERROUS SULPHATE; FENTANYL PATCH, ROXICET
Patient Outcome(s) Other;
Patient Age23 YR
-
-